Table S4 from PIK3CA Mutation in the ShortHER Randomized Adjuvant Trial for Patients with Early HER2+ Breast Cancer: Association with Prognosis and Integration with PAM50 Subtype

Abstract

Differentially expressed genes in HER2-enriched tumors according to PIK3CA mutation.